Browsing by Author Jin, Jie

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 169 next >
Issue Date Title Author(s)
2007 Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma Zhang, Qlan;Ying, Jianming;Zhang, Kai;Li, Hongyu;Ng, Ka Man;Zhao, Yayuan;He, Qun;Yang, Xinyu;Xin, Dianqi;Liao, Shuen-Kuei;Tao, Qian;Jin, Jie
2010 Aberrant Promoter Methylation of DLEC1, a Critical 3p22 Tumor Suppressor for Renal Cell Carcinoma, is Associated With More Advanced Tumor Stage Zhang, Qian;Ying, Jianming;Li, Jisheng;Fan, Yichao;Poon, Fan Fong;Ng, Ka Man;Tao, Qian;Jin, Jie
2015 Abiraterone acetate after docetaxel-based chemotherapy failure in Asian patients with metastatic castration-resistant prostate cancer Ye, Dingwei;Zou, Qing;Sun, Zhongquan;Sun, Yinghao;Li, Changling;Du, Chuanjun;Chen, Zhiwen;Shan, Yuxi;Huang, Yiran;Jin, Jie;Ye, Zhang Qun;Xie, Liping;Feng, Yi;De Porre, Peter;Liu, Weiping;Ye, Dingwei
2015 Abiraterone acetate after docetaxel-based chemotherapy failure in Asian patients with metastatic castration-resistant prostate cancer Ye, Dingwei;Zou, Qing;Sun, Zhongquan;Sun, Yinghao;Li, Changling;Du, Chuanjun;Chen, Zhiwen;Shan, Yuxi;Huang, Yiran;Jin, Jie;Ye, Zhang Qun;Xie, Liping;Feng, Yi;De Porre, Peter;Liu, Weiping;Ye, Dingwei
2016 Abiraterone acetate for metastatic castration-resistant prostate cancer after docetaxel failure: A randomized, double-blind, placebo-controlled phase 3 bridging study Sun, Yinghao;Zou, Qing;Sun, Zhongquan;Li, Changling;Du, Chuanjun;Chen, Zhiwen;Shan, Yuxi;Huang, Yiran;Jin, Jie;Ye, Zhang Qun;Xie, Liping;Lin, Guowen;Feng, Yi;De Porre, Peter;Liu, Weiping;Ye, Dingwei
2016 Activation of bitter taste receptors (tas2rs) relaxes detrusor smooth muscle and suppresses overactive bladder symptoms Zhai, Kui;Yang, Zhiguang;Zhu, Xiaofei;Nyirimigabo, Eric;Mi, Yue;Wang, Yan;Liu, Qinghua;Man, Libo;Wu, Shiliang;Jin, Jie;Ji, Guangju
2019 Activation of cGMP/PKG/p65 signaling associated with PDE5-Is downregulates CCL5 secretion by CD8(+) T cells in benign prostatic hyperplasia Jin, Song;Xian, Peng;Liu, Jie;Yang, Yang;Hu, Shuai;Sheng, Jindong;He, Qun;Yu, Wei;Han, Wenke;Jin, Jie;Peng, Jing
Jun-2020 Acute kidney injury in solitary kidney patients after partial nephrectomy: incidence, risk factors and prediction Zhu, Kun;Song, Haifeng;Zhang, Zhenan;Ma, Binglei;Bao, Xiaoyuan;Zhang, Qian;Jin, Jie
Jun-2021 Adolescents experienced more treatment failure than children with chronic myeloid leukemia receiving imatinib as frontline therapy: a retrospective multicenter study Dou, Xuelin;Zheng, Fangyuan;Zhang, Liqiang;Jin, Jie;Zhang, Yanli;Liu, Bingcheng;Meng, Li;Zhu, Xiaofan;Lu, Zesheng;Jia, Yueping;Liu, Huilan;Lin, Hai;Zhou, Li;Zhao, Xielan;Yang, Wei;Sun, Hui;Qian, Sixuan;Ma, Hongxia;Du, Xin;Bai, Qingxian;Xu, Na;Meng, Fanjun;Jia, Zhilin;Di, Haixia;Zhang, Leping;Jiang, Qian
2015 Adult renal cell carcinoma with rhabdoid differentiation: incidence and clinicopathologic features in Chinese patients Yang, Xinyu;Xi, Chenguang;Jin, Jie;Zhou, Liqun;Su, Jinwei;Liu, Libo;Liu, Yuli
2007 Angiotension II receptor 1 blocker modifies the expression of apoptosis-related proteins and transforming growth factor-beta 1 in prostate tissue of spontaneously hypertensive rats Yu, Wei;Zhao, Ya-Yuan;Zhang, Zhi-Wen;Guo, Ying-Lu;Jin, Jie
Sep-2022 Apatinib enhances chemosensitivity of ABT-199 in diffuse large B-cell lymphoma Shi, Yuanfei;Ye, Jing;Shen, Huafei;Xu, Yi;Wan, Rui;Ye, Xiujin;Jin, Jie;Xie, Wanzhuo
2016 Association of ABO blood types and clinicopathological features of ureteral transitional cell carcinoma in a single-center in China Huang, Haichao;Li, Xin;Jin, Jie
2015 Axitinib versus sorafenib as a second-line therapy in Asian patients with metastatic renal cell carcinoma: results from a randomized registrational study Qin, Shukui;Bi, Feng;Jin, Jie;Cheng, Ying;Guo, Jun;Ren, Xiubao;Huang, Yiran;Tarazi, Jamal;Tang, Jie;Chen, Connie;Kim, Sinil;Ye, Dingwei
2018 Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma Jin, Jie;Okamoto, Rumiko;Yoon, Sung-Soo;Shih, Lee-Yung;Zhu, Jun;Liu, Ting;Hong, Xiaonan;Pei, Lixia;Rooney, Brendan;van de Velde, Helgi;Huang, Huiqiang
Jun-2020 CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study Qian, Jie-Jing;Hu, Xiaoxia;Wang, Ying;Zhang, Yi;Du, Juan;Yang, Min;Tong, Hongyan;Qian, Wen-Bin;Wei, Juying;Yu, Wenjun;Lou, Yin-Jun;Mao, Liping;Meng, Hai Tao;You, Liang-Shun;Wang, Libing;Li, Xia;Huang, Xin;Cao, Li-Hong;Zhao, Jian-Zhi;Yan, Xiao Yan;Chen, Yu-Bao;Chen, Yu;Zhang, Su-Jiang;Jin, Jie;Hu, Jiong;Zhu, Hong-Hu
2012 A Case of Central Metanephric Adenoma Successfully Treated With Laparoscopic Nephron-sparing Surgery Xu, Ben;Zhang, Qian;Jin, Jie
2017 Caspofungin Treatment for Pulmonary Invasive Fungal Disease in Hematology Patients: A Retrospective Study in a Clinical Practice Setting in China Zhang, Xiaohui;Hu, Jiong;Hu, Yu;Huang, He;Jin, Jie;Li, Juan;Liu, Qifa;Shao, Zonghong;Wang, Jianxiang;Wang, Quanshun;Wu, Depei;Huang, Xiaojun
2017 CD8+T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway Yang, Yang;Hu, Shuai;Liu, Jie;Cui, Yun;Fan, Yu;Lv, Tianjing;Liu, Libo;Li, Jun;He, Qun;Han, Wenke;Yu, Wei;Sun, Yin;Jin, Jie
2016 Characteristics of Chinese patients with advanced prostate cancer: A muliticentre, non-interventional, observational, prospective, registry study of docetaxel. He, Dalin;Sun, Zhongquan;Guo, Jianming;Zhang, Zhigen;Shan, Yuxi;Ma, Lulin;Li, Hanzhong;Jin, Jie;Huang, Yiran;Xiao, Jiaquan;Wei, Qiang;Ye, Dingwei
Showing results 1 to 20 of 169 next >